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ABSTRACT ThetypeVIIsecretionsystemsareconservedacrossmycobacterialspeciesandinmanyGram-positivebacteria.While
thewell-characterizedEsx-1pathwayisrequiredforthevirulenceofpathogenicmycobacteriaandconjugationinthemodelor-
ganism Mycobacterium smegmatis, Esx-3 contributes to mycobactin-mediated iron acquisition in these bacteria. Here we show
thatseveralEsx-3componentsareindividuallyrequiredforfunctionunderlow-ironconditionsbutthatatleastone,the
membrane-bound protease MycP3 of M. smegmatis, is partially expendable. All of the esx-3 mutants tested, including the
mycP3msmutant,failedtoexportthenativeEsx-3substratesEsxHmsandEsxGmstoquantiﬁablelevels,asdeterminedbytar-
getedmassspectrometry.Althoughwewereabletorestorelow-irongrowthtothe esx-3mutantsbygeneticcomplementation,
wefoundawiderangeofcomplementationlevelsforproteinexport.Indeed,minutequantitiesofextracellularEsxHmsand
EsxGmsweresufﬁcientforironacquisitionunderourexperimentalconditions.TheapparentseparationofEsx-3functionin
ironacquisitionfromrobustEsxGmsandEsxHmssecretioninthemycP3msmutantandinsomeofthecomplemented esx-3mu-
tantscompelsreexaminationofthestructure-functionrelationshipsfortypeVIIsecretionsystems.
IMPORTANCE MycobacteriahaveseveralparalogoustypeVIIsecretionsystems,Esx-1throughEsx-5.WhereasEsx-1isrequired
for pathogenic mycobacteria to grow within an infected host, Esx-3 is essential for growth in vitro. We and others have shown
thatEsx-3isrequiredforsiderophore-mediatedironacquisition.Inthiswork,weidentifyindividualEsx-3componentsthat
contributetothisprocess.AsintheEsx-1system,mostmutationsthatabolishEsx-3proteinexportalsodisruptitsfunction.
Unexpectedly,however,ultrasensitivequantitationofEsx-3secretionbymultiple-reaction-monitoringmassspectrometry
(MRM-MS)revealedthatverylowlevelsofexportweresufﬁcientforironacquisitionundersimilarconditions.Althoughpro-
teinexportclearlycontributestotypeVIIfunction,therelationshipisnotabsolute.
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O
ne of the many strategies evolved by Mycobacterium tubercu-
losis to prevent clearance by the host is protein export via
Esx-1(1–3),aspecializedsecretionsystemthatisalsorequiredfor
conjugation in M. smegmatis (4, 5). There are four paralogous esx
lociintheM.tuberculosisgenome(6–8),butthefunctionsofthese
Esx systems are just beginning to be revealed (9–19, 55).
Whereas Esx-1 is essential for the in vivo growth of pathogenic
mycobacteria,thereisstrongevidencethatEsx-3isessentialforin
vitro growth (12, 13, 19, 20). Building on observations that esx-3
expression responds to iron and zinc availability (21, 22), we and
othershavedemonstratedthatEsx-3isrequiredformycobacterial
growth in low iron (12, 13, 19). Mycobacteria acquire iron by at
least two siderophore pathways—exochelin, present in fast-
growingspecies,suchasM.smegmatis,andmycobactin,presentin
nearly all species (23–25)—in addition to a porin-based, low-
afﬁnity iron transport system (26) and the heme uptake system
(27, 28). Epistasis experiments using M. smegmatis strains with
deﬁciencies in Esx-3 and in the production of exochelin or myco-
bactin show that Esx-3 functions in iron acquisition via the my-
cobactin pathway (13). Moreover, addition of puriﬁed, iron-
bound mycobactin does not rescue the low-iron growth defect,
suggesting that Esx-3 is required for optimal utilization of the
siderophores (13).
The organizations and contents of the esx-1 and esx-3 loci are
similar (8). Both encode small, secreted proteins; Esx-1 contains
EsxB (Cfp-10) and EsxA (Esat-6), and Esx-3 contains the paralo-
gous EsxG and EsxH proteins (Fig. 1). We use the systematic no-
menclature proposed by Bitter et al. (29). Genes that ﬂank esxB/A
and esxG/H include those encoding EccC3 (a putative FtsK/
SpoIIIE ATPase that is paralogous to EccCa1/EccCb1 [where the
“a” and “b” sufﬁxes indicate the parts of the split gene and the
subscript number refers to the esx-1 gene cluster]), EspG3 (a pu-
tative soluble protein of unknown function that is paralogous to
EspG1), EccD3 (paralogous to the hypothesized secretion channel
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protease MycP1) (8).
MultiplestudiesontheEsx-1systemsupportamodelinwhich
the FtsK/SpoIIIE ATPase EccCa1/EccCb1 provides energy to pro-
pel EsxB and EsxA across the cytoplasmic membrane via a trans-
location pore composed of EccD1 (30–32). It is not yet clear how
typeVIIsubstrateproteinscrossthecellenvelope.Esx-1maysim-
ply export these proteins across the cell envelope into the extra-
cellularspace.Alternatively,itmayactonlyacrossthecytoplasmic
membrane and require a mechanism for driving substrates across
theremainderofthethickmycobacterialcellwall.Suchastructure
may be composed of yet-unidentiﬁed components or of EsxA,
EsxB, and possibly other unlinked Esx-1 substrates (33, 34).
EspG1, EccCa1/EccCb1, EccD1, and MycP1 are required for
bothEsxBandEsxAexportandEsx-1functioninmostmycobac-
terialspeciestested(3,5,35–41),promptingearlyspeculationthat
EsxB and EsxA are the effector proteins of the secretion system.
However,therehavesincebeenreportsofseveralEsx-1mutations
that abolish function without affecting EsxB and EsxA export (4,
35, 42, 43), as well as two genetic perturbations that prevent M.
tuberculosis EsxB (EsxBmt) and EsxAmt secretion but do not alter
M. tuberculosis virulence (44). These studies suggest that the rela-
tionship between protein export and Esx function may be more
complicated than previously assumed.
Esx-3exportsEsxH(13)and,asweshowhere,EsxG.Wefound
that several M. smegmatis Esx-3 components were individually
required for export of EsxHms and EsxGms and for iron acquisi-
tion. However, we also observed low or even no detectable secre-
tion for some strains that were able to grow to wild-type levels in
lowiron.Theapparentseparationofthephenotypessuggestsnew
models for the associations between Esx structure and function.
RESULTS
Esx-3 components are required for low-iron growth. We have
previously shown that Esx-3 is required for mycobacterial growth
in low-iron medium via the mycobactin pathway (13). The secre-
tion system is essential for growth in M. tuberculosis (12, 13, 20),
however,complicatingeffortstotestthecontributionsofindivid-
ual Esx-3 components to the function of the entire system. The
modelorganismM.smegmatiscangrowwithoutfunctionalEsx-3
in normal growth medium. We therefore constructed unmarked,
in-frame deletions of esx-3 genes in M. smegmatis (see Fig. S1 in
the supplemental material). Because M. smegmatis has partially
redundant siderophore-based iron acquisition mechanisms, i.e.,
FIG 1 Schematic diagram of gene conservation in mycobacterial esx-1 and esx-3 loci. , the M. smegmatis esx-1 locus has a slightly different organization than
the M. tuberculosis region from espJ to espB (5, 8); , there is no MSMEG_0625, mycP3ms is MSMEG_0624, and eccE3ms is MSMEG_0626. We use the
nomenclatureproposedbyBitteretal.(29).Brieﬂy,thetermseccandesp,respectively,standforesxconservedcomponentandEsx-1secretion-associatedprotein.
Thealphabeticsufﬁxofconservedesxgenesfollowsthegeneorderintheesx-1locus.Thenumericalsubscriptattheendofthegenenamereferstotheesxcluster
towhichthegenebelongs.WealsoprovidethestandardM.tuberculosisandM.smegmatisgenenumbersatthebeginningandendofeachlocusforcomparison.
Although not listed in the NCBI or SmegmaList databases, MSMEG_0620 is esxGms and MSMEG_0621 is esxHms.
Siegrist et al.
2
® mbio.asm.org May/June 2014 Volume 5 Issue 3 e01073-14the mycobactin and exochelin pathways (24), we combined each
esx-3 deletion with an insertional mutation in fxbA, which en-
codesaformyltransferaserequiredforexochelinsynthesis.Previ-
ously,wefoundthatthefxbAeccC3msmutantgrowssigniﬁcantly
more slowly than the fxbA strain in low-iron medium (13). Al-
though the fxbA esxGHms, fxbA espG3ms, and fxbA eccD3ms
mutants display similar low-iron growth deﬁciencies, the fxbA
mycP3msstrainhasalesspronounceddefect(Fig.2and3).These
strains are rescued by the presence of iron (Fig. S2) and upon
reintroduction of the corresponding esx-3 gene (13) (Fig. 2).
Thus, M. smegmatis growth in low iron requires the Esx-3 com-
ponents EccC3ms, EsxGms/EsxHms, EspG3ms, and EccD3ms, with a
more minor contribution from MycP3ms.
Esx-3componentscontributetooptimalmycobactinutiliza-
tion. Previously, we constructed an M. smegmatis strain that con-
tains insertions in both fxbA, described above, and mbtD, which
encodes a polyketide synthase required for mycobactin synthesis
(13). This mutant, which lacks both means of high-afﬁnity iron
uptake, does not grow in iron-depleted medium but can be res-
cued by the addition of puriﬁed, iron-bound mycobactin or car-
boxymycobactin (13). However, the siderophores fail to rescue
the fxbA esx-3 mutant, suggesting that Esx-3 is required for op-
timal utilization of iron bound to mycobactins (13). In the ab-
senceoftheexochelinpathway,deletionoftheesx-3geneeccC3ms,
esxGHms,espG3ms,oreccD3msimpairsiron-boundmycobactinuti-
lization in M. smegmatis to an extent similar to that after removal
oftheentireEsx-3system,whereasdeletionofmycP3mshasamore
modest effect (Fig. 3). We conclude that the Esx-3 components
EccC3ms, EsxGms/EsxHms, EspG3ms, and EccD3ms are critical to the
function of the M. smegmatis Esx-3 system in mycobactin-
mediated iron acquisition.
SecretionofEsxHmsandEsxGmsrequiresEsx-3components.
Secretion of EsxB and EsxA is generally linked to Esx-1 function;
that is, most mutations that abolish export of these proteins also
inhibit virulence (M. tuberculosis and M. marinum) or conjuga-
tion (M. smegmatis) (3–5, 35–40). Our work on the Esx-3 system
demonstrates that EccC3ms, EsxGms/EsxHms, EspG3ms, and
EccD3ms are required for function in mycobactin-mediated iron
acquisitionandthatMycP3msplaysamorelimitedrole(Fig.2and
3).Previously,weshowedthatexportofheterologouslyexpressed,
myc-taggedEsxHdependsonironlevelsandonthepresenceofan
intactEsx-3locus(13).TotestwhetherthelossofindividualEsx-3
FIG2 Esx-3 components contribute to low-iron growth. The growth of the fxbA and fxbA esx-3 M. smegmatis mutants in low-iron medium was monitored by
determining their optical densities at 600 nm. pJ, pJEB402 vector; pJ-[gene name], pJEB402 containing the indicated M. smegmatis gene. The experiments were
performed 2 to 6 times in triplicate. Representative data are shown, and error bars represent the standard deviations from the replicates.
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the abundance of representative EsxGms and EsxHms peptides in
cultureﬁltratesandselectedwhole-cellextractsbytargeted,quan-
titativemassspectrometry(MS).Assaysforpeptidesfromeachof
these proteins were constructed using stable-isotope dilution MS
(SID-MS) and multiple-reaction-monitoring MS (MRM-MS)
(45, 46). For these experiments, we grew strains with intact exo-
chelin production in medium with a level of iron chelation that
induces EsxH secretion (13) but does not produce differences in
growth. Deletion of the esx-3 gene eccC3ms, esxGHms, espG3ms,o r
eccD3msresultsinsupernatantlevelsofEsxHmsandEsxGmsthatare
below the limit of quantitation (LOQ) across two biological rep-
licates(Fig.4andS3toS5inthesupplementalmaterial).Interest-
ingly, although the mycP3ms mutation causes a much smaller de-
fect in low-iron growth than the other mutations (Fig. 2), there is
acomparabledecreaseinsupernatantpeptidesinthreeofthefour
data sets to levels below the LOQ (Fig. 4 and S3 to S5).
We ﬁnd most of the detectable EsxHms and EsxGms in the su-
pernatant fraction of wild-type M. smegmatis (Fig. 4 and S5). To
test whether the observed lack of secretion by the esx-3 mutants
reﬂectsageneraldecreaseinproteinexpression,wealsocompared
the whole-cell extracts of the wild type, espG3ms mutant, and
complemented espG3ms strain. The amounts of EsxHms and
EsxGms were similar across the samples (Fig. S5), suggesting that
theobservedchangeinsupernatantabundanceaccuratelyreports
an export defect. The general lack of protein accumulation in the
whole-cell extract, furthermore, implies that the cell tightly regu-
latestheabundanceofwhatwehypothesizeisasmall,cytoplasmic
pool of EsxHms and EsxGms.
These data were consistent with our previous ﬁndings that
Esx-3isrequiredfortheexportofEsxHms-myc(13).Unlikenative
EsxGms and EsxHms, however, the tagged protein accumulates in
the bacterial cytoplasm to robust levels (13). Therefore, we con-
ﬁrmedthemassspectrometryﬁndingsbyconstructinganewplas-
midthatconstitutivelyexpressesesxGmsandFLAG-taggedesxHms
and comparable amounts of EsxHms-FLAG in cell-associated and
supernatantfractionsofwild-typeandesx-3mutantM.smegmatis
strains. In agreement with the MRM-MS results, we were consis-
tentlyunabletodetectEsxHms-FLAGfromthesupernatantsofthe
eccC3ms, espG3ms, eccD3ms, and mycP3ms mutants or from
any of the whole-cell extracts (Fig. 5).
DISCUSSION
We found that EccC3ms, EspG3ms, and EccD3ms are core Esx-3
componentsthatarerequiredforbothmycobactin-mediatediron
acquisition and EsxGms and EsxHms export. The M. tuberculosis
homologs EccC3mt, EspG3mt, and EccD3mt are all predicted to be
necessary for in vitro growth (20, 47, 48). The Esx-1 paralogs
EccCa1/EccCb1, EspG1, and EccD1 are required for virulence in
pathogenic mycobacteria and conjugation in M. smegmatis and,
with the exception of EspG1mt (35, 42), for EsxB and EsxA export
(3–5, 35–40).
We have also identiﬁed a potential accessory Esx-3 compo-
nent, MycP3, that is necessary for EsxG and EsxH export (Fig. 4
and 5) but not absolutely required for mycobactin-mediated iron
acquisition(Fig.2and3).Theﬁrstobservationisnotunexpected,
as mutants that lack MycP1 fail to secrete EsxB and EsxA (36, 41).
The data on the contribution of MycP to Esx function are less
clear; although MycP1ms is required for DNA transfer in M. smeg-
matis to the same or greater extent as other Esx-1 components (4,
36),mycP1mtdisruptioninM.tuberculosisresultsinadelayedphe-
notypeinmicecomparedtothephenotypesresultingfromtrans-
poson insertions in other esx-1 genes (49). More recent work cor-
roborates an in vivo growth defect from loss of MycP1mt (41), but
the lack of a direct comparison to other esx-1 mutant strains pre-
cluded analysis of the relative defect. Like the other esx-3 genes,
mycP3mt is essential for M. tuberculosis growth in vitro (47). Given
that MycP1 and MycP3 likely have different substrate speciﬁcities
FIG 3 Loss of Esx-3 components is not rescued by exogenous mycobactin. Growth of fxbA, fxbA mbtD, and fxbA esx-3 mutants in unsupplemented, low-iron
mediumorinlow-ironmediumcontaining20g/mlmycobactinSat48h.Theexperimentwasperformedatleastthreetimesintriplicate.Representativedata
are shown and are expressed as percentages of the fxbA mutant’s growth in low-iron medium. Error bars indicate the standard errors of the proportions.
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® mbio.asm.org May/June 2014 Volume 5 Issue 3 e01073-14FIG4 EsxGms(A)andEsxHms(B)abundancesinwild-typeandesx-3mutantsupernatants.ProteinconcentrationsforEsxGmsandEsxHmswereapproximated,
respectively, by measuring the concentration of the FVEVSAK peptide alone and by summing the individual concentrations above the LOD of three of the
methionineformsofAMATTHEQNTMAMSARpeptides(Fig.S4).DottedlinesshowtheLOQ(Fig.S4).Theexperimentswereperformedintechnicalreplicate
acrosstwobiologicalreplicates.Theproteinabundancedatafromoneofthebiologicalreplicatesareshownhereingraphicalandtableformat,andthedatafrom
the other replicate are reported in the Fig. S5 table. comp, complemented; ND, none detected.
FIG 5 Export of epitope-tagged EsxHms in the presence or absence of Esx-3 components. Anti-FLAG immunoblotting of whole-cell lysates (wcl) and culture
supernatants(sup)fromwild-typeandesx-3M.smegmatiscontainingpSYMP-esxGHms-FLAGinlow-ironmedium.AllstrainscontaineithertheemptypJEB402
vector or pJEB402 containing the complementing gene. The antibody against the intracellular protein RNAP is a loading and lysis control. The experiment was
performed twice with similar results.
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Esx component varies according to the secretion apparatus with
which it associates.
Despite our attempts to avoid polar effects by constructing
in-frame, unmarked, full gene deletions, it is possible that the
mutations altered the expression of downstream genes. However,
this does not appear to be the case for at least the mycP3ms mu-
tant, as neither mycP3ms alone nor mycP3ms alongside the down-
stream eccE3ms restored EsxHms-FLAG export (not shown). Tran-
scription of the esx-3 locus varies according to iron and zinc
availability (13, 21, 22). It is possible that expression of the com-
plementing genes from a heterologous, constitutive promoter al-
tered the stoichiometry of Esx-3 components, which in turn re-
sulted in suboptimal protein secretion.
We attempted to measure secreted proteins using native anti-
bodies and Western blotting. However, the antisera that we were
able to obtain had low afﬁnity and poor speciﬁcity, making quan-
titation difﬁcult. Given the tendency of secretion systems to be
refractory to reporter fusions (52), we turned to MRM-MS to
measurebacterialproteinexport.Thislabel-freemethodishighly
speciﬁc and sensitive and is likely to have broad applicability to
bacterial protein secretion studies (53).
Precise quantitation of secretion by MRM-MS revealed a sur-
prising dynamic range in the levels of EsxG and EsxH export that
support iron acquisition. We were able to restore esx-3 mutant
growth to wild-type levels by adding iron to the growth medium
(Fig. S2) or by complementing the deleted genes (Fig. 2). How-
ever, the same genetic constructs varied widely in their abilities to
restoreEsxGmsandEsxHmsexport(Fig.4and5).Onlyafractionof
secreted wild-type EsxGms and EsxHms levels appeared necessary
for complementation; we observed robust low-iron growth
(Fig.2)concomitantwithproteinexportthatspanned3ordersof
magnitude, from 1% to approximately 40% of wild-type levels
(Fig.4).Werecentlyfoundthattheessentialdrugtargetsdihydro-
folatereductaseand D-alanineracemasearepresentinexcess(54).
It is possible that wild-type M. smegmatis exports EsxGms and
EsxHms at levels much greater than those needed to support low-
iron growth. This raises the possibility that the locus has multiple
functions, each with different secretion requirements.
Indeed, there is growing appreciation that the relationship be-
tween Esx protein export and function is more complex than ini-
tially assumed. There are now numerous reports of Esx-1 muta-
tions that attenuate pathogenic mycobacteria without impacting
secretion.Forexample,complementationofthenaturalesx-1mu-
tant M. microti (Fig. 1) with a panel of cosmids containing intact
ormutantversionsoftheM.tuberculosisesx-1regionrevealedthat
espF1mt and espG1mt are required for virulence but not EsxBmt and
EsxAmt export (35). Deletion of these genes from M. tuberculosis
also resulted in attenuation without impacting the secretion of
EsxBmt and EsxAmt (42). In a different example, disruption of
disulﬁde bond formation in the Esx-1 substrate EspA attenuated
M. tuberculosis virulence but had no effect on EsxBmt or EsxAmt
secretion (43). Finally, transposon insertions in espJms, espKms,
and espBms impaired conjugation but not EsxBms export (4). In
aggregate, these studies show that secretion of EsxB and EsxA is
not sufﬁcient for Esx-1 function in virulence.
Recently,Chenandcoworkersisolatedtwopointmutationsof
EspAmt that block EsxBmt and EsxAmt export in vitro but do not
attenuate M. tuberculosis (44). Although they did not rule out a
roleforthehostenvironmentinpermittingsecretioninvivo,these
datasuggestthatexportoftheseproteins,atleastinlargeamounts,
may not be strictly required for virulence. Similarly, we found a
mutation that inhibits Esx protein secretion but permits partial
function: loss of mycP3ms blocked the export of native EsxGms and
EsxHms and FLAG-tagged EsxHms (Fig. 4 and 5), yet the fxbA
mycP3ms mutant retained some ability to grow in low iron
(Fig. 2). We also found that very low quantities of EsxGms and
EsxHms secretion were sufﬁcient to reinstate low-iron growth to
some of our complemented esx-3 mutants (Fig. 2 and 4). Impor-
tantly, dissection of the Esx-3 system in the model organism
M. smegmatis allowed us to compare the two phenotypes, EsxG
and EsxH export and mycobactin-mediated iron acquisition, un-
der similar in vitro conditions.
Why are not protein secretion and iron utilization completely
congruent in our mutant strains? This is especially puzzling given
that the genome of M. smegmatis, unlike M. tuberculosis, does not
encode the closely related paralogs EsxR and EsxS, which might
otherwise be hypothesized to substitute for EsxG and EsxH func-
tion (8). One reason may be the existence of multiple Esx sub-
strates, each with its own requirements for export and contribu-
tions to function. The roles of EspG and EspB are particularly
informative in this regard. Inactivation of the paralogous espG1,
espG5, or, as we show in Fig. 4, espG3 gene generally prevents the
export of Esx substrate proteins (11, 17, 37, 42). However, in
M. tuberculosis, loss of EspG5mt did not produce an obvious phe-
notype(55),whileEspG1mtwasrequiredforfullvirulencebutnot
EsxBmt or EsxAmt secretion (35, 42). Interestingly, EspG1 and
EspG5 have been shown to interact speciﬁcally with cognate Pro-
Glu(PE)/Pro-Pro-Glu(PPE)proteins(56,57)andhavebeenpro-
posed to serve as chaperones for Esx secretion of these substrates
(57). These data suggest that the PE/PPE proteins have export
requirements and functional contributions distinct from those of
other type VII substrates. Similarly, the secretion and activity of
the Esx-1 substrate EspB appear to be independent of EsxA (58,
59) and EsxB (60).
Our data are consistent with at least three general models. It is
conceivablethatlossofEsx-3functionproducesglobalchangesin
cell wall structure such that protein localization is affected by
changes both in secretion and in the compartment into which
translocation occurs. We note that while esx-3 mutants do not
have altered sensitivities to SDS, vancomycin, rifampin (Fig. S5),
ampicillin, or kanamycin (19), at least when iron is not limiting,
we are unable to rule out this model. A second possibility is that
Esx-3 secretes a protein or proteins necessary for iron acquisition
and that this protein requires the core components EccC3, EccD3,
and EspG3 but not EsxG, EsxH, or MycP3 for export. Although it
ispossiblethatEsx-3functioninironacquisitiondoesnotrequire
any EsxG and EsxH secretion, we think that this is unlikely given
thatthefxbAesxGHmsstrainhasacomplementablegrowthphe-
notype in low iron. A third model is that both EsxG and EsxH are
substrates and structural components of or chaperones for the
Esx-3 machinery. In this scenario, EsxG and EsxH are exported
across the cytoplasmic membrane via EccD3 into the periplasm,
wheretheyarepoisedtodeliveryet-unidentiﬁedeffectorsofferri-
mycobactinuptakeacrosstheremainderofthecellwall(Fig.6).If
EsxG and EsxH indeed act within or across the mycobacterial
envelope, some of the protein detected in the supernatants of
broth-grown mycobacteria may represent sloughing of protein
associated with the cell wall (33, 34).
While type VII secretion systems have important functions
Siegrist et al.
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clear. Clearly, protein export contributes to but does not entirely
accountfortypeVIIfunction.MorecompletemodelsfortypeVII
structure-function relationships will require better characteriza-
tion of secreted components and assays for protein-protein inter-
actions that occur between Esx components in the cytosol or
membrane (55, 61).
MATERIALS AND METHODS
Bacterial strains and growth conditions. M. smegmatis was cultured in
chelatedSauton’smediumcontaining60mlglycerol,0.5gKH2PO4,2.2g
citric acid monohydrate, 4 g asparagine, and 0.05% Tween 80 per liter.
After adjusting the pH to 7.4, the medium was stirred for 1 to 2 days at
room temperature with 10 g Chelex 100 resin (Sigma). The medium was
ﬁltered, and 1 g MgSO4·7H2O was added as a sterile solution. For iron
starvation experiments, bacteria were ﬁrst inoculated from frozen stocks
into 7H9 medium, subcultured once in chelated Sauton’s medium, and
then diluted 1:1,000 in chelated Sauton’s medium without antibiotics
containingeither100M2,2=-dipyridylor12.5MFeCl3.Formycobac-
tin complementation experiments, bacteria were directly diluted 1:1,000
froma7H9startercultureintochelatedSauton’smediumwithorwithout
ferri-mycobactin S.
Strain construction. To create the M. smegmatis esx-3 gene deletions,
1-kb regions ﬂanking eccC3ms, espG3ms, eccD3ms, mycP3ms, and esxGHms
were ampliﬁed from M. smegmatis genomic DNA, stitched together by
PCR, and cloned into the suicide vector pJM1. The pJM1 vector contains
ahygromycin-chloramphenicolresistancecassetteandthecounterselect-
able marker sacB. M. smegmatis transformants were screened by PCR
usingprimersspeciﬁctotheﬂanksaswellastoregionswithintheputative
deletion.CandidateswereconﬁrmedbyPCRusingmultipleprimersout-
side the ﬂanks. To construct fxbA insertional mutants, the esx-3 deletion
strains were transformed with the pSES-fxbA suicide vector (13) and
screened by standard methods. The absence of exochelin production was
conﬁrmed for candidate mutants by patching them to chrome azurol
(CAS) agar.
Complementing constructs for each mutant were constructed by am-
FIG6 OnemodelforEsx-3functioninwhichEsxGandEsxHarebothsubstratesandchaperonesorstructuralcomponentsofthesecretionapparatus.IrtAand
IrtB are components of a mycobactin transporter system (63–65). We hypothesize that at least one of the functions of EsxG and EsxH is to ferry effectors of
iron-loaded mycobactin uptake within or across the mycobacterial cell wall. In the absence of an Esx-3 core component, such as EccD3, we do not detect EsxG
or EsxH in culture supernatants. We hypothesize that the proteins are not exported across the cytoplasmic membrane under this condition and therefore are
completely unable to contribute to iron acquisition. In contrast, although supernatants from fxbA mycP3ms cultures do not contain detectable EsxG or EsxH,
the strain itself retains intermediate growth under low-iron conditions. We suggest the MycP3 protease may be an accessory Esx-3 component that is required
either for a stable EsxG-EsxH structure or for optimal chaperone activity. Thus, in the absence of this accessory factor, EsxG and EsxH may still traverse the
cytoplasmic membrane to the periplasm but be only partially functional.
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under the MOP promoter in the integrative pJEB402 plasmid (38). The
construct containing esxGms and esxHms C-terminally tagged with FLAG
wasgeneratedbyamplifyingtheregionfromgenomicM.smegmatisDNA
and cloning it under the control of the hsp60 promoter of pSYMP (62).
SID, MRM-MS. (i) Labeled-peptide internal standards. Figure S3
shows the amino acid sequences of the proteins EsxGms and EsxHms and
the peptides that were selected for quantitative analysis of these proteins
bymultiple-reaction-monitoringmassspectrometry(MRM-MS).Apep-
tide from each of the proteins was selected based on their detection in the
discovery data by high electrospray MS signal responses and because they
have unique sequences as determined by a search of the nonredundant
M.tuberculosisproteindatabase(NCBInr).Fourdifferentversionsofthe
peptideAMATTHEQNTMAMSARfortheEsxHmsproteinwereselected,
all of which were observed in the discovery data.
(ii) Peptide synthesis. Five signature peptides from the two proteins,
EsxGms (FVEVSAK) and EsxHms (AMATTHEQNTMAMSAR, with four
forms of differing oxidized methionine states), were synthesized with a
single,uniformlylabeled[13C6]lysineor[13C6]arginineattheirCtermini
by New England Peptide (Gardner, MA). Unlabeled 12C-labeled forms of
each peptide were also synthesized by New England Peptide. Synthetic
peptides were puriﬁed to 99% purity and analyzed by amino acid anal-
ysis (New England Peptide). Calculations of concentrations were based
upon amino acid analysis.
(iii)MRM-MSassayconﬁguration.Thelimitsofdetectionandquan-
tiﬁcation (LOD and LOQ, respectively) for the signature peptides used to
obtainquantitativemeasurementsineachofthe22samples(5mutants,5
complemented mutants and 1 wild-type strain in each of two biological
process replicates) are shown in Fig. S4. A 12-point response curve was
generatedbyspikinglightpeptideversionsofthe5analytepeptidesovera
range of 0 to 50 fmol/1 g of digested supernatant protein and a ﬁxed
amount of heavy, internal-standard peptides (1 fmol/1 g) of the super-
natant protein mix from the esxGHms sample. This supernatant of the
esxGHms sample was used as the background matrix for response curve
generation,asitdoesnotexpresstheproteinsofinterest.Eachconcentra-
tion point was analyzed by liquid chromatography (LC)–MRM-MS on a
Waters Xevo TQ mass spectrometer (Milford, MA) in three technical
replicates.TheLODwasdeterminedbytheLinnetstatisticalmethod,and
the lower LOQ was calculated as 3 times the LOD. The blank sample
consistsoftheesxGHmssamplewithonlytheisotopicallylabeled(heavy)
peptides spiked in.
(iv) Nano-LC–MRM-MS. Tryptic peptides were prepared from cul-
ture supernatants (see below) and reconstituted in 80 l of 0.1% formic
acid, and 1 g/liter of each sample was used for MRM-MS analysis.
Nano-LC–MRM-MS was performed on a Xevo TQ mass spectrometer
(WatersCorporation,Milford,MA)coupledtoaNanoAcuityLCsystem.
Chromatography was performed with solvent A (0.1% formic acid) and
solvent B (100% acetonitrile in 0.1% formic acid). Each sample was in-
jected with a full-loop injection of 1 l on a Waters, packed, Reprosil,
3-m-bead column (75-m internal diameter [ID], 10-m ID tip open-
ing)witha2.5-inby20-mIDsprayneedle.Samplewaselutedat300nl/
min,withagradientof3to7%solventBfor8min,7to40%solventBfor
34 min, and 40 to 90% solvent B for 3 min, with a total data acquisition
time of 80 min. Data were acquired with a stable column temperature of
35°C. Collision energy (CE) was optimized for the maximum transmis-
sion and sensitivity of each MRM transition by LC–MRM-MS. Three
transitions were monitored per peptide and acquired at unit resolution
both in the ﬁrst and in the third quadrupole (Q1 and Q3). In general,
transitions were chosen based upon relative abundance and a mass-to-
charge ratio (m/z) greater than the precursor m/z in the full-scan tandem
MS(MS/MS)spectrumrecordedontheXevoTQmassspectrometer.The
ﬁnal MRM-MS method consisted of 10 optimized transitions for each of
the ﬁve selected peptides from the two target proteins. One of the four
peptides (AMATTHEQNTMAMSAR) was not used for data analysis due
to a weak signal.
(v) MRM-MS data analysis. Data analysis was performed using the
Skyline Software Module (https://skyline.gs.washington.edu/). The rela-
tive ratios of the three transitions selected and optimized for the ﬁnal
MRM assay were predeﬁned in the absence of the target proteins (i.e., in
buffer) for each peptide using the 13C-labeled internal standards. The
mostabundanttransitionforeachpairwasusedforquantiﬁcationunless
interference in this channel was observed. The 12C/13C peak area ratios
wereusedtocalculateconcentrationsofthetargetpeptidesineachsample
by the following equation: measured concentration  peak area ratio 
(1 fmol/l internal standard).
Sample preparation for MRM-MS analysis. Strains were inoculated
from frozen stocks in 7H9 medium with appropriate antibiotics and
grownwithshakingfor48h.Thecellswerethenwashedtwiceinchelated
Sauton’s medium, normalized by their optical densities at 600 nm
(OD600s), and inoculated 1:500 into chelated Sauton’s medium. Cultures
weregrownfor48htologphase,and8ODunitswereharvested.Bacteria
in the pellets were lysed by bead beating, and the lysates were stored at
80°C. Protein from the supernatant was precipitated by the trichloro-
aceticacid(TCA)methodanddissolvedinurea-ammonium-bicarbonate
buffer(8Murea,50mMammoniumbicarbonate).Proteinconcentration
was measured by the Bradford assay of diluted samples.
One hundred micrograms of protein was reduced by 20 mM dithio-
threitol (DTT) and alkylated using 50 mM iodoacetamide. Prior to being
digested with trypsin, samples were diluted to a urea concentration of
0.6 M by the addition of 50 mM ammonium bicarbonate. Trypsin (Pro-
mega Gold) digestion was carried out at an enzyme-to-substrate ratio of
1:50. The peptides were desalted using Sep-Pak cartridges (Sep-Pak C18
1-cc[50-mg]Vaccartridges;Waters)asdescribedbythemanufacturer.In
the ﬁnal step, samples were eluted in 80% acetonitrile and 0.1% formic
acid and evaporated to complete dryness in a vacuum centrifuge.
Immunoblotting. Strains were inoculated from frozen stocks into
7H9 medium and grown to saturation. They were then diluted 1:500 in
chelatedSauton’smedium,growntosaturation,anddiluted1:100inche-
lated Sauton’s medium. Proteins from cell pellets and supernatants of
culturesgrownfor12hinthisfashionwererunon10to20%Tris-Tricine
gels(Invitrogen)andrevealedusingananti-FLAGantibody.Anantibody
to RNA polymerase (RNAP; Neoclone W0023), an intracellular protein,
served as a loading and lysis control.
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